The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
Abstract
We measured antibody (anti-HCV) to hepatitis C virus, which causes non-A, non-B hepatitis, by radioimmunoassay in prospectively followed transfusion recipients and their donors. Of 15 patients with chronic non-A, non-B hepatitis documented by liver biopsy, all seroconverted for the antibody; of 5 with acute resolving non-A, non-B hepatitis, 3 (60 percent) seroconverted. The development of anti-HCV was delayed (mean delay, 21.9 weeks after transfusion, or 15 weeks after the onset of clinical hepatitis) and took approximately one year in one patient. Antibody has persisted in 14 of the 15 patients with chronic disease (mean follow-up, greater than or equal to 6.9 years; maximum, greater than or equal to 12), but has disappeared in the 3 with acute resolving disease after a mean of 4.1 years. Anti-HCV was detected in samples of donor serum given to 14 (88 percent) of the 16 anti-HCV-positive patients for whom all donor samples were available. Only 33 percent of the anti-HCV-positive donors tested had an elevated serum concentration of alanine aminotransferase; 54 percent were positive for antibody to the hepatitis B core antigen (anti-HBc). We conclude that hepatitis C virus is the predominant agent of transfusion-associated non-A, non-B hepatitis and that screening of donors for anti-HCV could prevent the majority of cases of the disease. "Surrogate" assays for anti-HBc and alanine aminotransferase would have detected approximately half the anti-HCV-positive donors involved in the transmission of hepatitis that we identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Self-citationAn Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., et al. (1989) · Science · doi:10.1126/science.2496467 · Cited by 3,346
Self-citation(2011) · Hepatogastroenterology · doi:10.5754/hge11453 · Cited by 1,254
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
Dienstag, J. L. (1983) · Gastroenterology · doi:10.1016/0016-5085(83)90336-0 · Cited by 500
Bréchot, C., Degos, F., Lugassy, C., Thiers, V., Zafrani, S., Franco, D., Bismuth, H., Trépo, C., Benhamou, J.-P., Wands, J., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501313120503 · Cited by 459
Importance of Heterosexual Activity in the Transmission of Hepatitis B and Non-A, Non-B Hepatitis
Alter, M. J. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430090063034 · Cited by 435
KOZIOL, D. E., HOLLAND, P. V., ALLING, D. W., MELPOLDER, J. C., SOLOMON, R. E., PURCELL, R. H., HUDSON, L. M., SHOUP, F. J., KRAKAUER, H., & ALTER, H. J. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-488 · Cited by 328
Self-citationStevens, C. E., AACH, R. D., HOLLINGER, F. B., MOSLEY, J. W., SZMUNESS, W., KAHN, R., WERCH, J., & EDWARDS, V. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-733 · Cited by 302
Donor Transaminase and Recipient Hepatitis: Impact on Blood Transfusion Services
Alter, H. J. (1981) · JAMA · doi:10.1001/jama.246.6.630 · Cited by 270
Self-citationPosttransfusion Non-A, Non-B Hepatitis: Physicochemical Properties of Two Distinct Agents
Bradley, D. W., Maynard, J. E., Popper, H., Cook, E. H., Ebert, J. W., McCaustland, K. A., Schable, C. A., & Fields, H. A. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.2.254 · Cited by 212
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
The Risk of Transfusion-Transmitted Viral Infections
Schreiber, G. B., Busch, M. P., Kleinman, S. H., & Korelitz, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342601 · Cited by 1,867
Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent
Linnen, J., Wages, J., Zhang-Keck, Z.-Y., Fry, K. E., Krawczynski, K. Z., Alter, H., Koonin, E., Gallagher, M., Alter, M., Hadziyannis, S., et al. (1996) · Science · doi:10.1126/science.271.5248.505 · Cited by 1,359
Self-citationOkamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y., Tanaka, T., Sato, K., Tsuda, F., Miyakawa, Y., et al. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-3-673 · Cited by 1,242
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.
Saito, I., Miyamura, T., Ohbayashi, A., Harada, H., Katayama, T., Kikuchi, S., Watanabe, Y., Koi, S., Onji, M., & Ohta, Y. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6547 · Cited by 1,089
Metadata
- Authors
- Alter, H. J., Purcell, R. H., Shih, J. W., Melpolder, J. C., Houghton, M., Choo, Q.-L., & Kuo, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1989-11-30
- Volume
- 321
- Issue
- 22
- Pages
- 1494-1500
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1974879228
- Cited by
- 1,658
- References
- 11
- FWCI
- 115.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis. https://app.cochat.ai/papers/10.1056/nejm198911303212202
- The paper
- Alter, H. J., Purcell, R. H., Shih, J. W., Melpolder, J. C., Houghton, M., Choo, Q.-L., & Kuo, G. (1989). Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis. New England Journal of Medicine. https://doi.org/10.1056/nejm198911303212202
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.